Physician profile
Tu Tran
NPI 1376570184
$1,772.53
in general payments reported to CMS, 2019-2025
8 companies · $14.97 in 2025
The $14.97 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $451 · 2021: $415 · 2022: $329 · 2023: $42.77 · 2024: $261 · 2025: $14.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,247.57 | 2019-2025 | |
| Abbvie INC. | $131.40 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $129.01 | 2023-2024 | Voquezna |
| Nestle Healthcare Nutrition INC. | $79.02 | 2022 | |
| Merck Sharp & Dohme LLC | $71.55 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.23 | 2020-2022 | |
| Redhill Biopharma INC. | $25.40 | 2022 | |
| Avanos Medical | $17.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tu Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.